Capstone Investment Advisors
GH icon

Capstone Investment Advisors’s Guardant Health GH Stock Holding History

Capstone Investment Advisors’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,239
Closed -$229K – 1695
2025
Q4 		$229K Sell
2,239
-35,560
-94% -$3.18M ﹤0.01% 1463
2025
Q3 		$2.36M Buy
37,799
+22,657
+150% +$1.23M ﹤0.01% 713
2025
Q2 		$788K Buy
+15,142
New +$676K ﹤0.01% 938
2024
Q1 		– Sell
-12,468
Closed -$337K – 2407
2023
Q4 		$337K Buy
+12,468
New +$327K ﹤0.01% 1542
2022
Q3 		– Sell
-24,062
Closed -$971K – 1701
2022
Q2 		$971K Buy
24,062
+17,057
+243% +$845K ﹤0.01% 1040
2022
Q1 		$464K Buy
+7,005
New +$479K ﹤0.01% 1520

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capstone Investment Advisors's GH Position: Q1 2026 in Review

Capstone Investment Advisors sold out of Guardant Health (GH) in Q1 2026, closing a stake of 2,239 shares — an estimated $229K sold.

Capstone Investment Advisors first reported a position in GH in Q1 2022 and held it in 6 quarters. The position peaked at $2.36M in Q3 2025. 483 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • Capstone Investment Advisors reported no remaining Guardant Health position as of Q1 2026 after selling out during the quarter.
  • Capstone Investment Advisors sold 2,239 Guardant Health shares in Q1 2026, an estimated $229K.
  • Capstone Investment Advisors first reported a position in Guardant Health in Q1 2022 and held it in 6 quarters.
  • Capstone Investment Advisors's Guardant Health position peaked at $2.36M in Q3 2025.
  • 483 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Capstone Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.